查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
性傳播疾病診斷市場：按類型、設備類型（實驗室設備、護理點設備）、最終用戶（實驗室測試、護理點測試）劃分，2023-2028 年
市場調查報告書
商品編碼
1237088

性傳播疾病診斷市場：按類型、設備類型（實驗室設備、護理點設備）、最終用戶（實驗室測試、護理點測試）劃分，2023-2028 年

Sexually Transmitted Disease Diagnostics Market by Type, Device Type (Laboratory Devices, Point of Care Devices), End User (Laboratory Testing, Point of Care Testing), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2022 年，全球性傳播疾病 (STD) 診斷市場規模將達到 987.1 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 1359.4 億美元，2023 年至 2028 年的增長率 (CAGR) 為 5.39%。 性病流行率上升、公眾對早期診斷意識的提高以及家庭性病檢測試劑盒的推出是推動市場的主要因素。

性傳播疾病 (STD) 診斷是指為識別和確認是否存在 STD 而進行的測試、測試和拭子培養。 它還包括血液、體液樣本和尿液測試，以檢測特定 STD 抗體和抗原的存在。 廣泛用於生殖器皰疹、衣原體、淋病、梅毒、陰蝨、滴蟲、獲得性免疫缺陷症候群（愛滋病）、細菌性陰道病、疥瘡、大塊疣等各種性病的檢測和篩查。 性病診斷有助於早期發現和準確治療，預防不孕症，保護胎兒免受感染，並最大限度地減少疾病的傳播。 這些診斷還可以降低可能的長期風險、增強自信並幫助醫生深入了解疾病及其原因。

性傳播疾病 (STD) 診斷的市場趨勢

  • 無保護措施的性交和藥物濫用引起的性傳播疾病 (STD) 流行率上升是推動市場增長的關鍵因素。 STD 診斷廣泛用於檢測各種 STD 病原體，如細菌、病毒和寄生蟲，具有很高的準確性和可靠性，使醫療保健提供者能夠確定適當的治療方法，並幫助母親和嬰兒。有助於預防疾病傳播和改善臨床結果患者。 此外，提高公眾對性病早期發現和診斷的認識，可以預防不孕症、先天缺陷、癌症、失明、骨骼畸形、腦損傷和智力低下等長期並發症，它起到了生長因子的作用。 此外，政府採取各種舉措提高人們對性健康和性病檢測的認識，並通過教育活動、研討會和社交媒體廣告消除相關的社會恥辱感，這些舉措正在推動市場增長。 此外，引入具有成本效益、安全、準確、方便、快速結果和保護隱私的家庭 STD 測試套件正在對市場增長產生積極影響。 此外，最近開發了一種基於人工智能 (AI) 的移動應用程序，該應用程序可以分析個人生殖器的數字圖像以診斷性傳播疾病，從而更容易獲得性傳播疾病檢測、維護機密並保護個人信息。市場的增長已經對市場的增長也產生了積極的影響。 預計將推動市場增長的其他因素包括醫療保健行業的顯著增長、通過電子商務輕鬆獲得性病診斷試劑盒以及增加對新型診斷技術研發的投資。

主要市場細分

  • IMARC Group 分析了全球性傳播疾病 (STD) 診斷市場每個細分市場的主要趨勢，並預測了 2023 年至 2028 年在全球、區域和國家層面的情況。 該報告根據類型、設備類型和最終用戶對市場進行分類。

本報告中回答的關鍵問題

  • 到目前為止，全球性傳播疾病 (STD) 診斷市場的表現如何？未來幾年將如何發展？
  • 全球性傳播疾病 (STD) 診斷市場的市場促進因素、抑制因素和機遇是什麼？
  • 每種促進因素□□、抑制因素和機會對全球性傳播疾病 (STD) 診斷市場有何影響？
  • 主要的區域市場是什麼？
  • 哪些國家/地區構成了最具吸引力的性傳播疾病 (STD) 診斷市場？
  • 按類型劃分的市場細分情況如何？
  • 性傳播疾病 (STD) 診斷市場上最有吸引力的類型是什麼？
  • 基於設備類型的市場細分是什麼？
  • 哪些設備類型在性傳播疾病 (STD) 診斷市場上最具吸引力？
  • 最終用戶的市場細分情況如何？
  • 性傳播疾病 (STD) 診斷市場中最有吸引力的最終用戶在哪裡？
  • 全球性傳播疾病 (STD) 診斷市場的競爭結構如何？
  • 全球性傳播疾病 (STD) 診斷市場的主要參與者/公司有哪些？

內容

第 1 章前言

第 2 章：範圍和方法論

  • 調查目的
  • 利益相關者
  • 數據來源
    • 主要資訊
    • 次要資訊
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第 3 章執行摘要

第 4 章介紹

  • 概覽
  • 主要行業趨勢

第 5 章全球性傳播疾病 (STD) 診斷市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按類型劃分的市場細分

  • 衣原體檢測
    • 市場趨勢
    • 市場預測
  • 梅毒試驗
    • 市場趨勢
    • 市場預測
  • 淋病測試
    • 市場趨勢
    • 市場預測
  • 單純皰疹病毒檢測
    • 市場趨勢
    • 市場預測
  • 人乳頭瘤病毒檢測
    • 市場趨勢
    • 市場預測
  • 人類免疫缺陷病毒檢測
    • 市場趨勢
    • 市場預測
  • Chunkroid檢查
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章按設備類型劃分的市場細分

  • 實驗室設備
    • 市場趨勢
    • 主要細分市場
      • 熱循環儀-PCR
      • 橫向流動閱讀器
      • 流式細胞儀
      • 吸光度□標儀：□聯免疫吸附測定 (ELISA)
      • 其他
    • 市場預測
  • 護理點 (PoC) 設備
    • 市場趨勢
    • 主要細分市場
      • 智能手機芯片（微流體 + ICT）
      • 便攜式/台式/快速診斷套件
    • 市場預測

第 8 章最終用戶市場細分

  • 實驗室測試
    • 市場趨勢
    • 市場預測
  • 護理點測試
    • 市場趨勢
    • 市場預測

第 9 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 關於市場趨勢
      • 市場預測
    • 印度
      • 關於市場趨勢
      • 市場預測
    • 韓國
      • 關於市場趨勢
      • 市場預測
    • 澳大利亞
      • 關於市場趨勢
      • 市場預測
    • 印度尼西亞
      • 市場趨勢
      • 市場預測
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場預測

第 10 章促進因素、抑制因素和機會

  • 概覽
  • 促進因素
  • 抑制因素
  • 機會

第 11 章價值鏈分析

第 12 章波特五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章價格分析

第 14 章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
      • Abbott Laboratories
      • Becton Dickinson and Company
      • BioMerieux SA
      • Bio-Rad Laboratories Inc.
      • Cepheid（Danaher Corporation）
      • F. Hoffmann-La Roche AG
      • Hologic Inc.
      • Qiagen N.V.
      • Quidel Corporation
      • Siemens Healthineers AG（Siemens AG）

    請注意，這只是部分公司，所有公司都包含在報告中。

Product Code: SR1523A353_Report

The global sexually transmitted disease (STD) diagnostics market size reached US$ 98.71 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 135.94 Billion by 2028, exhibiting a growth rate (CAGR) of 5.39% during 2023-2028. The rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits represent some of the key factors driving the market.

Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.

Sexually Transmitted Disease (STD) Diagnostics Market Trends:

  • The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth. Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) - based mobile applications that can diagnose STDs by analyzing digital images of an individual's private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each segment of the global sexually transmitted disease (STD) diagnostics market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, device type, and end user.

Type Insights:

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Others
  • The report has provided a detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the type. This includes chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus , chancroid testing, and others. According to the report, chlamydia testing represented the largest segment.

Device Type Insights:

  • Laboratory Devices
  • Thermal Cycler - PCR
  • Lateral Flow Readers
  • Flow Cytometers
  • Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
  • Others
  • Point of Care (PoC) Devices
  • Phone Chips (Microfluidics + ICT)
  • Portable/Bench Top/Rapid Diagnostic Kits
  • A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the device type has also been provided in the report. This includes laboratory devices (thermal cycler - PCR, lateral flow readers, flow cytometers, absorbance microplate reader - enzyme linked immunosorbent assay (ELISA), and others) and point of care (PoC) devices (phone chips (microfluidic + ICT) and portable/bench top/rapid diagnostic kits). According to the report, laboratory devices accounted for the largest market share.

End User Insights:

  • Laboratory Testing
  • Point of Care (PoC) Testing
  • A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the end user has also been provided in the report. This includes laboratory and point of care (PoC) testing. According to the report, laboratory testing accounted for the largest market share.

Regional Insights:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
  • What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the device type?
  • Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
  • What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
  • Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sexually Transmitted Disease (STD) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Chlamydia Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Syphilis Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gonorrhea Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Herpes Simplex Virus Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Human Papilloma Virus Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Human Immunodeficiency Virus Testing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Chancroid Testing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Laboratory Devices
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Thermal Cyclers - PCR
      • 7.1.2.2 Lateral Flow Readers
      • 7.1.2.3 Flow Cytometers
      • 7.1.2.4 Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Point of Care (PoC) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Phone Chips (Microfluidics + ICT)
      • 7.2.2.2 Portable/Bench Top/Rapid Diagnostic Kits
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Laboratory Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Point of Care Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 BioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid (Danaher Corporation)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Hologic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Qiagen N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Quidel Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Sexually Transmitted Disease Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Device Type (in %), 2022
  • Figure 6: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Sexually Transmitted Disease Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Sexually Transmitted Disease Diagnostics Industry: Value Chain Analysis
  • Figure 83: Global: Sexually Transmitted Disease Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sexually Transmitted Disease Diagnostics Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Types (in Million US$), 2023-2028
  • Table 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Device Type (in Million US$), 2023-2028
  • Table 4: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Sexually Transmitted Disease Diagnostics Market: Competitive Structure
  • Table 7: Global: Sexually Transmitted Disease Diagnostics Market: Key Players